Works in Progress: Using Administrative Data to Estimate the Prevalence of Progressive Fibrosing Interstitial Lung Disease

被引:0
作者
Bowman, Willis S. [1 ]
Dempsey, Timothy [2 ,3 ]
机构
[1] Univ Calif Davis, Div Pulm Crit Care & Sleep Med, Sacramento, CA 95817 USA
[2] US Air Force, David Grant Med Ctr, Travis Airforce Base, CA USA
[3] Mayo Clin, Robert D Patricia E Kern Ctr Sci Hlth Care Delive, Rochester, MN USA
关键词
D O I
10.1513/AnnalsATS.202203-276ED
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:1095 / 1097
页数:4
相关论文
共 11 条
  • [1] The Burden of Progressive-Fibrosing Interstitial Lung Diseases
    Cottin, Vincent
    Teague, Rhiannon
    Nicholson, Lindsay
    Langham, Sue
    Baldwin, Mike
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [2] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Walsh, S. L. F.
    Inoue, Y.
    Richeldi, L.
    Kolb, M.
    Tetzlaff, K.
    Stowasser, S.
    Coeck, C.
    Clerisme-Beaty, E.
    Rosenstock, B.
    Quaresma, M.
    Haeufel, T.
    Goeldner, R-G
    Schlenker-Herceg, R.
    Brown, K. K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18) : 1718 - 1727
  • [3] George PM, 2020, LANCET RESP MED, V8, P925, DOI 10.1016/S2213-2600(20)30355-6
  • [4] Diagnosis, course and management of hypersensitivity pneumonitis
    Hamblin, Mark
    Prosch, Helmut
    Vasakova, Martina
    [J]. EUROPEAN RESPIRATORY REVIEW, 2022, 31 (163)
  • [5] The natural history of progressive fibrosing interstitial lung diseases
    Kolb, Martin
    Vasakova, Martina
    [J]. RESPIRATORY RESEARCH, 2019, 20 (1)
  • [6] 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease
    Kondoh, Yasuhiro
    Makino, Shigeki
    Ogura, Takashi
    Suda, Takafumi
    Tomioka, Hiromi
    Amano, Hirofumi
    Anraku, Masaki
    Enomoto, Noriyuki
    Fujii, Takao
    Fujisawa, Tomoyuki
    Gono, Takahisa
    Harigai, Masayoshi
    Ichiyasu, Hidenori
    Inoue, Yoshikazu
    Johkoh, Takeshi
    Kameda, Hideto
    Kataoka, Kensuke
    Katsumata, Yasuhiro
    Kawaguchi, Yasushi
    Kawakami, Atsushi
    Kitamura, Hideya
    Kitamura, Noboru
    Koga, Tomohiro
    Kurasawa, Kazuhiro
    Nakamura, Yutaro
    Nakashima, Ran
    Nishioka, Yasuhiko
    Nishiyama, Osamu
    Okamoto, Masaki
    Sakai, Fumikazu
    Sakamoto, Susumu
    Sato, Shinji
    Shimizu, Toshimasa
    Takayanagi, Noboru
    Takei, Reoto
    Takemura, Tamiko
    Takeuchi, Tohru
    Toyoda, Yuko
    Yamada, Hidehiro
    Yamakawa, Hideaki
    Yamano, Yasuhiko
    Yamasaki, Yoshioki
    Kuwana, Masataka
    [J]. RESPIRATORY INVESTIGATION, 2021, 59 (06) : 709 - 740
  • [7] Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
    Maher, Toby M.
    Corte, Tamera J.
    Fischer, Aryeh
    Kreuter, Michael
    Lederer, David J.
    Molina-Molina, Maria
    Axmann, Judit
    Kirchgaessler, Klaus-Uwe
    Samara, Katerina
    Gilberg, Frank
    Cottin, Vincent
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (02) : 147 - 157
  • [8] Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
    Raghu, Ganesh
    Collard, Harold R.
    Anstrom, Kevin J.
    Flaherty, Kevin R.
    Flemings, Thomas R.
    King, Talmadge E., Jr.
    Martinee, Fernando J.
    Brown, Kevin K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (10) : 1044 - 1048
  • [9] Rose DM, 2013, AM J RESP CRIT CARE, V187, P1269, DOI 10.1164/rccm.201204-0690LE
  • [10] Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States
    Singer, David
    Bengtson, Lindsay G. S.
    Conoscenti, Craig S.
    Laouri, Marianne
    Shetty, Sharash S.
    Anderson, Amy J.
    Brown, Kevin K.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (07) : 1112 - 1121